Kestra Advisory Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,817
Closed -$895K 3521
2025
Q4
$895K Sell
8,817
-8,435
-49% -$677K ﹤0.01% 1741
2025
Q3
$944K Sell
17,252
-1,383
-7% -$69.1K ﹤0.01% 1634
2025
Q2
$990K Sell
18,635
-112
-0.6% -$5.69K ﹤0.01% 1483
2025
Q1
$812K Buy
18,747
+4,504
+32% +$228K ﹤0.01% 1515
2024
Q4
$800K Sell
14,243
-3,087
-18% -$192K ﹤0.01% 1541
2024
Q3
$1.18M Sell
17,330
-3,979
-19% -$225K 0.01% 1232
2024
Q2
$900K Buy
21,309
+734
+4% +$40.4K 0.01% 1385
2024
Q1
$1.42M Buy
20,575
+4,843
+31% +$306K 0.01% 1033
2023
Q4
$1.16M Sell
15,732
-1,574
-9% -$103K 0.01% 1046
2023
Q3
$1.18M Buy
17,306
+111
+0.6% +$9.42K 0.01% 919
2023
Q2
$1.61M Buy
17,195
+154
+0.9% +$12K 0.02% 763
2023
Q1
$1.16M Sell
17,041
-7,888
-32% -$507K 0.01% 873
2022
Q4
$1.23M Buy
24,929
+5,788
+30% +$236K 0.01% 959
2022
Q3
$622K Buy
19,141
+118
+0.6% +$4.87K 0.01% 1198
2022
Q2
$749K Buy
19,023
+2,543
+15% +$136K 0.01% 1110
2022
Q1
$1.15M Buy
16,480
+4,410
+37% +$322K 0.01% 892
2021
Q4
$939K Sell
12,070
-3,569
-23% -$315K 0.01% 1016
2021
Q3
$1.49M Buy
15,639
+1,131
+8% +$119K 0.01% 823
2021
Q2
$1.8M Buy
14,508
+1,876
+15% +$224K 0.02% 689
2021
Q1
$1.67M Sell
12,632
-724
-5% -$99.1K 0.02% 659
2020
Q4
$1.81M Buy
13,356
+2,168
+19% +$262K 0.02% 627
2020
Q3
$1.14M Buy
+11,188
New +$966K 0.02% 583

Other funds holding EXAS

Kestra Advisory Services's EXAS Position: Q1 2026 in Review

Kestra Advisory Services sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 8,817 shares — an estimated $895K sold.

Kestra Advisory Services first reported a position in EXAS in Q3 2020 and held it in 22 quarters. The position peaked at $1.81M in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Kestra Advisory Services reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 8,817 Exact Sciences shares in Q1 2026, an estimated $895K.
  • Kestra Advisory Services first reported a position in Exact Sciences in Q3 2020 and held it in 22 quarters.
  • Kestra Advisory Services's Exact Sciences position peaked at $1.81M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.